| My Account | Subscribe | Contact Us | Donate |
Home
- Kris Freeman Skis for Olympic Gold
- Good Insulin Injection Practices
- Etiquette for People without Diabetes
- Diabetes Technology and Intimacy
- An American in the UK: Healthcare for Type 1s
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Related Medications Threads on Diabetes Health Forums
Lantus
Updated 46 weeks ago
Insulin pens have been very popular in Europe for quite some time and interest is building steadily in the United States. Many people prefer an insulin pen over the standard syringe and vial because the pens are more convenient and more accurate. Pre-filled disposable insulin pens are the easiest of all, because you don't never have to install a new cartridge when the pen is empty-you just toss it out.
4 comments - Apr 28, 2009 -
The first time Chris Matthews heard the words "high blood sugar" was in 2002 at a doctor's office in Washington, DC, where he was being treated for malaria after a trip to Zimbabwe. He didn't pay a lot of attention to the warning about his glucose levels after a blood test. The malaria was subsequently cured, and he continued at his usual rapid-fire pace, traveling the country giving speeches about his best-selling books ("Life is a Campaign" is his latest; "Hardball" is his best known) and his work both inside the White House, where he was a speechwriter for President Carter, and outside, where he was administrative assistant to House Speaker Tip O'Neill on Capitol Hill. Then there's his work on television, where he is host of Hardball on MSNBC and the Chris Matthew Show, which airs on Sundays just before Meet the Press on NBC. He stayed busy, and his schedule remained overbooked. He let the warning about high blood sugar go into the background-so far back it was out of sight and definitely out of mind. Besides, there just wasn't any room in his life to deal with it.
10 comments - Mar 26, 2009 -
At the recent 44th annual meeting of the European Association for the Study of Diabetes (EASD), sanofi-aventis announced a study demonstrating that a basal-bolus insulin regimen with Lantus® once daily (basal insulin) and rapid-acting Apidra® (insulin glulisine [rDNA origin] injection) at mealtime (bolus insulin) resulted in significant A1c reductions from baseline as compared to pre-mixed insulin in people with type 2 diabetes.
5 comments - Sep 29, 2008 -
In a recent randomized study, 69 people with type 2 diabetes who were already taking metformin were given either Byetta or Lantus for a full year. When the results were in, Byetta came out ahead on several fronts.
10 comments - Dec 11, 2007 -
In an Italian study to compare once-daily injections of insulin glargine (Lantus) with once-daily injections of insulin detemir (Levemir), 24 patients with type 1 diabetes were treated for two weeks with either one or the other in a randomized double-blind study.
14 comments - Dec 4, 2007 -
You can make any insulin last longer by injecting a large enough shot. (See Scott King's column, "Why Smaller Shots of Insulin Get Absorbed Faster, Peak Sooner, and Are Out of Your System Quicker", for the math on this.) In fact, about 25 years ago, Dr. John Galloway of Eli Lilly and Company performed an important experiment that demonstrated this very fact.
6 comments - Nov 30, 2007 -
Novo Nordisk's Levemir, which came out about five years after sanofi-aventis's Lantus, constitutes about twenty percent of the long-acting basal insulin sold worldwide. Lantus, the only other long-acting insulin analogue, makes up the other eighty percent.
3 comments - Nov 27, 2007 -
In July, I flew from New York City to Phoenix to meet my new book agent. (Trust me, I would not have deliberately sought out 100-degree weather without good reason.) Always thinking ahead, I decided to bring along a fancy new bag specially insulated to keep my insulin cool. Alas, either the bag failed me, or I failed the bag.
3 comments - Nov 25, 2007 -
Lantus and Levemir have a lot in common. Both are basal insulin formulas, which means that they last for a long time in the body and act as background insulin, with a slow feed that mimics the constant low output of insulin produced by a healthy pancreas.
85 comments - Jul 17, 2007 -
The Cochrane Library recently conducted a review of studies to see if NPH is as good as Lantus and Levemir when used as a basal insulin for people with type 2 diabetes. Six studies comparing insulin glargine (Lantus) to NPH (Neutral Protamine Hagedorn) were examined, as well as two studies comparing insulin detemir (Levemir) to NPH.
0 comments - Jun 11, 2007 -